Author
Listed:
- Matteo Massara
(Humanitas Clinical and Research Center
Università degli Studi di Milano)
- Ornella Bonavita
(Humanitas Clinical and Research Center
Università degli Studi di Milano)
- Benedetta Savino
(Humanitas Clinical and Research Center
Università degli Studi di Milano)
- Nicoletta Caronni
(Humanitas Clinical and Research Center
Università degli Studi di Milano)
- Valeria Mollica Poeta
(Humanitas Clinical and Research Center
Humanitas University)
- Marina Sironi
(Humanitas Clinical and Research Center)
- Elisa Setten
(Humanitas Clinical and Research Center
Università degli Studi di Milano)
- Camilla Recordati
(Fondazione Filarete)
- Laura Crisafulli
(Humanitas Clinical and Research Center
CNR)
- Francesca Ficara
(Humanitas Clinical and Research Center
CNR)
- Alberto Mantovani
(Humanitas Clinical and Research Center
Humanitas University
Queen Mary University of London)
- Massimo Locati
(Humanitas Clinical and Research Center
Università degli Studi di Milano)
- Raffaella Bonecchi
(Humanitas Clinical and Research Center
Humanitas University)
Abstract
Atypical chemokine receptors (ACKRs) are regulators of leukocyte traffic, inflammation, and immunity. ACKR2 is a scavenger for most inflammatory CC chemokines and is a negative regulator of inflammation. Here we report that ACKR2 is expressed in hematopoietic precursors and downregulated during myeloid differentiation. Genetic inactivation of ACKR2 results in increased levels of inflammatory chemokine receptors and release from the bone marrow of neutrophils with increased anti-metastatic activity. In a model of NeuT-driven primary mammary carcinogenesis ACKR2 deficiency is associated with increased primary tumor growth and protection against metastasis. ACKR2 deficiency results in neutrophil-mediated protection against metastasis in mice orthotopically transplanted with 4T1 mammary carcinoma and intravenously injected with B16F10 melanoma cell lines. Thus, ACKR2 is a key regulator (checkpoint) of mouse myeloid differentiation and function and its targeting unleashes the anti-metastatic activity of neutrophils in mice.
Suggested Citation
Matteo Massara & Ornella Bonavita & Benedetta Savino & Nicoletta Caronni & Valeria Mollica Poeta & Marina Sironi & Elisa Setten & Camilla Recordati & Laura Crisafulli & Francesca Ficara & Alberto Mant, 2018.
"ACKR2 in hematopoietic precursors as a checkpoint of neutrophil release and anti-metastatic activity,"
Nature Communications, Nature, vol. 9(1), pages 1-11, December.
Handle:
RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-018-03080-8
DOI: 10.1038/s41467-018-03080-8
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-018-03080-8. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.